Comparative Pharmacology
Head-to-head clinical analysis: MICONAZOLE 3 COMBINATION PACK versus SELSUN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MICONAZOLE 3 COMBINATION PACK versus SELSUN.
MICONAZOLE 3 COMBINATION PACK vs SELSUN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Miconazole inhibits fungal cytochrome P450 14α-demethylase (CYP51), thereby blocking the conversion of lanosterol to ergosterol, an essential component of the fungal cell membrane. This leads to increased membrane permeability and fungal cell death.
Selenium sulfide is an antifungal agent that inhibits the growth of Malassezia species by reducing selenium to elemental selenium, which is toxic to the fungus. It also reduces sebum production via unknown mechanisms.
Intravaginal: 1 applicatorful (100 mg) at bedtime for 3 consecutive nights.
Apply 5-10 mL of 2.5% selenium sulfide lotion to affected areas of scalp, lather with water, leave on for 2-3 minutes, then rinse thoroughly. Use twice weekly for 2 weeks, then once weekly for maintenance.
None Documented
None Documented
Terminal elimination half-life is 20-25 hours (intravaginal administration). This long half-life supports a 3-day dosing regimen, maintaining therapeutic concentrations.
Not well defined due to minimal systemic absorption; topical application yields negligible plasma levels.
Renal: approximately 10-20% as unchanged drug; fecal: >50% as metabolites; biliary: minor route. The majority is eliminated via feces as metabolites, reflecting hepatic metabolism and biliary excretion.
Selenium sulfide is minimally absorbed; absorbed portions are excreted renally (approx. 80-90%) and fecally (10-20%).
Category A/B
Category C
Antifungal
Antifungal/Antiseborrheic